Matches in Wikidata for { <http://www.wikidata.org/entity/Q90392752> ?p ?o ?g. }
- Q90392752 description "article scientifique publié en 2019" @default.
- Q90392752 description "artículu científicu espublizáu en payares de 2019" @default.
- Q90392752 description "im November 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90392752 description "scientific article published on 01 November 2019" @default.
- Q90392752 description "wetenschappelijk artikel" @default.
- Q90392752 description "наукова стаття, опублікована 1 листопада 2019" @default.
- Q90392752 name "Efficacy and Safety of a Fixed Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg vs Betahistine Dihydrochloride 16 mg in Patients with Peripheral Vestibular Vertigo: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Non-in" @default.
- Q90392752 name "Efficacy and Safety of a Fixed Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg vs Betahistine Dihydrochloride 16 mg in Patients with Peripheral Vestibular Vertigo: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Non-in" @default.
- Q90392752 type Item @default.
- Q90392752 label "Efficacy and Safety of a Fixed Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg vs Betahistine Dihydrochloride 16 mg in Patients with Peripheral Vestibular Vertigo: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Non-in" @default.
- Q90392752 label "Efficacy and Safety of a Fixed Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg vs Betahistine Dihydrochloride 16 mg in Patients with Peripheral Vestibular Vertigo: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Non-in" @default.
- Q90392752 prefLabel "Efficacy and Safety of a Fixed Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg vs Betahistine Dihydrochloride 16 mg in Patients with Peripheral Vestibular Vertigo: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Non-in" @default.
- Q90392752 prefLabel "Efficacy and Safety of a Fixed Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg vs Betahistine Dihydrochloride 16 mg in Patients with Peripheral Vestibular Vertigo: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Non-in" @default.
- Q90392752 P1433 Q90392752-6BB46E3E-9CF8-4767-9DEA-CC8BAE511638 @default.
- Q90392752 P1476 Q90392752-2B62BC09-AF35-4327-A98B-8E1C5FB34F22 @default.
- Q90392752 P2093 Q90392752-151D46E6-8CB3-49E1-8B4C-6DF6D76DE638 @default.
- Q90392752 P2093 Q90392752-33F16013-4226-4C13-B270-CD445E81147E @default.
- Q90392752 P2093 Q90392752-443A4D5F-DA90-4ED4-A400-B7D61E51C9B8 @default.
- Q90392752 P2093 Q90392752-4CA5186B-6D0B-420E-8118-10DA77F72E64 @default.
- Q90392752 P2093 Q90392752-89CC5B5C-8A53-4071-A766-D4EB95275F94 @default.
- Q90392752 P2093 Q90392752-9874A8BF-239D-478D-911D-60C4DE3E79BD @default.
- Q90392752 P2093 Q90392752-9A18F15A-BA22-42F1-B650-33E489C19346 @default.
- Q90392752 P2093 Q90392752-A1C0C0DC-37D7-48DF-955B-2F8C5B37AE87 @default.
- Q90392752 P2093 Q90392752-B1089C3F-6888-4D50-B85D-24D2227F3A0A @default.
- Q90392752 P2860 Q90392752-028C3CA9-FD16-4FBE-A9AC-06655F7AD8A7 @default.
- Q90392752 P2860 Q90392752-072DEC49-F8BE-4863-A076-5CAE63AB302A @default.
- Q90392752 P2860 Q90392752-1195FAF2-3447-446A-A430-AF01136465A7 @default.
- Q90392752 P2860 Q90392752-18648EDB-5DA3-4214-A53C-B7DDD905163C @default.
- Q90392752 P2860 Q90392752-2602C154-501B-4D30-9F0A-183530F838DB @default.
- Q90392752 P2860 Q90392752-4E4CEEE6-5DD5-4E61-99E5-80DF24962030 @default.
- Q90392752 P2860 Q90392752-4E630FE7-C518-48FD-B839-1292FC37D3BD @default.
- Q90392752 P2860 Q90392752-5C5DE8EC-A3E9-4761-895D-67BDBBF4A521 @default.
- Q90392752 P2860 Q90392752-787C0298-43F0-4F9E-8395-8354C41E3521 @default.
- Q90392752 P2860 Q90392752-7F75BA90-138F-4CE2-B5CD-382A26769E14 @default.
- Q90392752 P2860 Q90392752-80C8F5D0-87B1-4BC7-ACDE-1D363C1B7740 @default.
- Q90392752 P2860 Q90392752-9025C185-2DD8-4658-8C1C-9D5A1336C3FF @default.
- Q90392752 P2860 Q90392752-910DE9D2-B976-40DB-90F8-0625F09F946C @default.
- Q90392752 P2860 Q90392752-9658228D-8A4B-4BB9-868D-B5042B1EEDF2 @default.
- Q90392752 P2860 Q90392752-9774F9A2-9494-4A47-9B45-051CDCA5FDCE @default.
- Q90392752 P2860 Q90392752-97EB85CE-B200-427C-89E8-BA5DEEB45504 @default.
- Q90392752 P2860 Q90392752-98971C57-CDE0-442A-B9C6-DDB961895590 @default.
- Q90392752 P2860 Q90392752-9E52C18C-6850-4284-BD16-122159D43D7F @default.
- Q90392752 P2860 Q90392752-A3FB5457-9723-427C-8261-0ADDA36AC3B7 @default.
- Q90392752 P2860 Q90392752-A58FC534-BA23-44B9-ADF6-55F3BE135F24 @default.
- Q90392752 P2860 Q90392752-B3DCA178-8AB7-4652-9FFE-8DB7309E3EF7 @default.
- Q90392752 P2860 Q90392752-C7AADEA0-B6F3-4E5D-948F-D4001D12C487 @default.
- Q90392752 P2860 Q90392752-C9E8FA12-D79D-46EB-908F-A8E2C87911C8 @default.
- Q90392752 P2860 Q90392752-D614B3C3-4AE2-4220-9DFF-074E225EDEFA @default.
- Q90392752 P2860 Q90392752-D8002CD5-D3F6-4B73-9062-F694F773BC2E @default.
- Q90392752 P2860 Q90392752-D8917214-5011-49B5-BF9D-20D11C9DDAAD @default.
- Q90392752 P2860 Q90392752-E7820473-918C-4A90-BB8F-AFE795745F0A @default.
- Q90392752 P2860 Q90392752-EC828090-5000-41A4-A170-32E73795BCA7 @default.
- Q90392752 P304 Q90392752-6F7BB647-BB55-469C-A7F8-68BE3FF5E5AC @default.
- Q90392752 P31 Q90392752-ECD64C9D-F4C5-4152-A2DC-F6756E2EE089 @default.
- Q90392752 P356 Q90392752-485F439F-9B81-404C-B8AD-DAA920ACD06E @default.
- Q90392752 P433 Q90392752-CE6B8BE9-EA06-4A2E-922C-95531023EC57 @default.
- Q90392752 P478 Q90392752-6B292D98-0C8A-4FF9-AE2C-9B65709E48DC @default.
- Q90392752 P577 Q90392752-F127F792-F022-4EBD-B04F-45E39F03EC09 @default.
- Q90392752 P698 Q90392752-3184FE88-CBDC-444F-B266-F9693784E30E @default.
- Q90392752 P921 Q90392752-48955369-9003-4146-A754-ABDB69F4F7B5 @default.
- Q90392752 P932 Q90392752-6660973A-C41A-4D6D-BD98-DD7F4FC2E1F6 @default.
- Q90392752 P356 S40261-019-00858-6 @default.
- Q90392752 P698 31571128 @default.
- Q90392752 P1433 Q15753215 @default.
- Q90392752 P1476 "Efficacy and Safety of a Fixed Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg vs Betahistine Dihydrochloride 16 mg in Patients with Peripheral Vestibular Vertigo: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Non-inferiority Clinical Trial" @default.
- Q90392752 P2093 "Ales Hahn" @default.
- Q90392752 P2093 "Alexander Paschinin" @default.
- Q90392752 P2093 "Arne W Scholtz" @default.
- Q90392752 P2093 "Bohdana Stefflova" @default.
- Q90392752 P2093 "Daniela Medzhidieva" @default.
- Q90392752 P2093 "Gerhard Weisshaar" @default.
- Q90392752 P2093 "Kai Schumacher" @default.
- Q90392752 P2093 "Natalia Kunelskaya" @default.
- Q90392752 P2093 "Sergey V Ryazantsev" @default.
- Q90392752 P2860 Q26471456 @default.
- Q90392752 P2860 Q28261280 @default.
- Q90392752 P2860 Q28261631 @default.
- Q90392752 P2860 Q33523165 @default.
- Q90392752 P2860 Q34268484 @default.
- Q90392752 P2860 Q34515517 @default.
- Q90392752 P2860 Q36833129 @default.
- Q90392752 P2860 Q37072674 @default.
- Q90392752 P2860 Q37560632 @default.
- Q90392752 P2860 Q38068745 @default.
- Q90392752 P2860 Q38157563 @default.
- Q90392752 P2860 Q39337898 @default.
- Q90392752 P2860 Q39378254 @default.
- Q90392752 P2860 Q42231810 @default.
- Q90392752 P2860 Q44312545 @default.
- Q90392752 P2860 Q44755988 @default.
- Q90392752 P2860 Q45008192 @default.
- Q90392752 P2860 Q46248801 @default.
- Q90392752 P2860 Q46491752 @default.
- Q90392752 P2860 Q46797370 @default.
- Q90392752 P2860 Q47131368 @default.
- Q90392752 P2860 Q51136958 @default.
- Q90392752 P2860 Q52936542 @default.
- Q90392752 P2860 Q53584979 @default.
- Q90392752 P2860 Q70315262 @default.
- Q90392752 P2860 Q80391800 @default.